Catalent Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Catalent, Inc., provides CDMO services, delivery technologies and manufacturing solutions to develop pharmaceuticals, biologics and consumer health products.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Catalent, Inc. creates positive Humankind Value on the whole, with much of its positive value coming from Healthcare R&D ($24.3 B), Pharmaceuticals ($12.0 B), and Economic Value ($2.7 B). The value associated with Healthcare R&D and Pharmaceuticals contains our estimation of 700,000 additional years lived by people worldwide. This firm can increase its Humankind Value by addressing Biofuel Production (-$316.0 M) and Greenhouse Gases (-$268.5 M). Healthcare R&D, Pharmaceuticals, Economic Value, Biofuel Production, and Greenhouse Gases are mostly or entirely a result of supply-chain relationships. While this company has a positive Humankind Value when studied in isolation, consideration of supply chain interactions pushes its Humankind Value higher.